Loading, Please Wait...
NASHUA, N.H., Sept. 03, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its executive management team will host an investor meeting at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago.
The event will be held on Monday, September 16, 2019 at 12:00 - 2 p.m. Central Time at the Marriott Marquis. To attend iCAD’s ASTRO investor meeting, please RSVP to Sara Parigian at email@example.com by September 9th, 2019.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Jessica Burns, iCAD
Jeremy Feffer, LifeSci Advisors